Back to today’s briefing

Story perspectives

Study Reveals Sleeping Pill May Raise Alzheimer's Risk

1/22/2025

49 8

Summary

Story summary

A groundbreaking 2022 study in Cell uncovers that Zolpidem, a common sleeping pill, may sabotage the brain's glymphatic system, crucial for clearing harmful waste. Lead researcher Natalie L. Hauglund warns this disruption could elevate the risk of Alzheimer's by preventing the removal of amyloid beta. Urgent further research on humans is essential to understand the full impact.

1 of 1

Story summary

A groundbreaking 2022 study in Cell uncovers that Zolpidem, a common sleeping pill, may sabotage the brain's glymphatic system, crucial for clearing harmful waste. Lead researcher Natalie L. Hauglund warns this disruption could elevate the risk of Alzheimer's by preventing the removal of amyloid beta. Urgent further research on humans is essential to understand the full impact.